# OnCo record rhoa-g17v (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/rhoa-g17v/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "rhoa-g17v" ;
  schema:name "RHOA G17V"@en ;
  schema:alternateName "RHOA G17V"@en, "RHOA Gly17Val"@en, "RHOA mutation"@en, "T-follicular-helper lymphoma mutation"@en ;
  schema:description "A single change in a small signalling protein, found in about two thirds of one kind of T-cell lymphoma. It is useful because it is specific to the tumour cells, while the other mutations in the same disease are also present in normal blood cells."@en ;
  schema:url <https://onco.cc/biomarkers/rhoa-g17v/> ;
  schema:dateModified "2026-09-30"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/ng.2872>, <https://doi.org/10.1038/ng.2873> ;
  onco:tag "biomarker", "lymphoma" ;
  onco:cancers <https://onco.cc/cancers/angioimmunoblastic-t-cell-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/rhoa/>, <https://onco.cc/targets/tet2/>, <https://onco.cc/targets/dnmt3a/>, <https://onco.cc/targets/fyn/> ;
  onco:drugs <https://onco.cc/drugs/azacitidine/>, <https://onco.cc/drugs/romidepsin/> ;
  onco:pathways <https://onco.cc/pathways/epigenetic-reprogramming/>, <https://onco.cc/pathways/clonal-haematopoiesis/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/driver-mutation/>, <https://onco.cc/terms/clonal-evolution-theory/> .